TipRanks
Ondine Biomedical, Inc. (DE:VF5)
FRANKFURT:VF5
Germany Market

Ondine Biomedical, Inc. (VF5) Cash flow

2 Followers

Ondine Biomedical, Inc. Cash Flow

DE:VF5's free cash flow for Q2 2026 was C$-13.27M. For the 2026 fiscal year, DE:VF5's free cash flow was decreased by C$-8.52M and operating cash flow was C$-13.16M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -23.90MC$ -15.49MC$ -13.65MC$ -16.34MC$ -12.54M
Investing Cash Flow
C$ -117.28KC$ -10.00KC$ -177.00KC$ -311.00KC$ -77.00K
Financing Cash Flow
C$ 24.28MC$ 21.74MC$ 3.79MC$ -275.00KC$ 41.90M
End Cash Position
C$ 10.58MC$ 9.93MC$ 3.14MC$ 13.27MC$ 29.87M
Free Cash Flow
C$ -24.02MC$ -15.50MC$ -13.83MC$ -16.66MC$ -12.62M
Currency in CAD

Ondine Biomedical, Inc. Cash Flow